Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 7, 2020; 26(5): 499-513
Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.499
Published online Feb 7, 2020. doi: 10.3748/wjg.v26.i5.499
Figure 2 E2F transcription factor 1 promotes the proliferation and inhibits the apoptosis of gastric cancer cells.
A: Cell cycle of each group was measured by flow cytometry; B: Cell apoptosis of each group was detected by flow cytometry; C: E2F1 promoted S-phase cell proliferation; D: E2F1 inhibited apoptosis. bP < 0.01 vs the NC sh group, cP < 0.05 vs the NC si group; and fP < 0.001 vs the NC si group.
- Citation: Zheng H, Wang JJ, Yang XR, Yu YL. Upregulation of miR-34c after silencing E2F transcription factor 1 inhibits paclitaxel combined with cisplatin resistance in gastric cancer cells. World J Gastroenterol 2020; 26(5): 499-513
- URL: https://www.wjgnet.com/1007-9327/full/v26/i5/499.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i5.499